Similar articles

• Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy.

  Guaraldi G, Ventura P, Albuzza M, Orlando G, Bedini A, Amorico G, Esposito R. Guaraldi G, et al. AIDS. 2001 Jan 5;15(1):137-8. doi: 10.1097/00002030-200101050-00025. AIDS. 2001. PMID: 11192861 No abstract available.
• Stavudine, lamivudine plus novel protease inhibitor therapy in antiretroviral-naive HIV-infected individuals treated for 24 weeks.

  Murphy RL. Murphy RL. Antivir Ther. 1999;4 Suppl 3:85-7. Antivir Ther. 1999. PMID: 16021877 Clinical Trial.
• Drug safety evaluation profile of stavudine plus lamivudine for HIV-1/AIDS infection.

  Mateo MG, Gutierrez Mdel M, Vidal F, Domingo P. Mateo MG, et al. Expert Opin Drug Saf. 2012 May;11(3):473-85. doi: 10.1517/14740338.2012.676639. Epub 2012 Apr 3. Expert Opin Drug Saf. 2012. PMID: 22468613
• HIV and AIDS. Gap between biology and reality in AIDS.

  Carr A, Cooper DA. Carr A, et al. Lancet. 1998 Dec 19-26;352 Suppl 4:SIV16. doi: 10.1016/s0140-6736(98)90278-1. Lancet. 1998. PMID: 9872163 Review. No abstract available.
• Guide to major clinical trials of antiretroviral therapy administered to patients infected with human immunodeficiency virus.

  Spooner KM, Lane HC, Masur H. Spooner KM, et al. Clin Infect Dis. 1996 Jul;23(1):15-27. doi: 10.1093/clinids/23.1.15. Clin Infect Dis. 1996. PMID: 8816123 Review. No abstract available.